AMBALAL SARABHAI ENTERPRISES
Back to Cashflow Statement
|
AMBALAL SARABHAI ENTERPRISES Last 5 Year Cash Flow from Financing Activities History
[Consolidated]
Mar2023 | Mar2022 | Mar2021 | Mar2020 | Mar2019 | |
---|---|---|---|---|---|
Cash Flow from Financing Activities | ₹9.09 Cr | ₹-19 Cr | ₹-5.84 Cr | ₹-14 Cr | ₹-6.07 Cr |
What is the latest Cash Flow from Financing Activities ratio of AMBALAL SARABHAI ENTERPRISES ?
Year | Cash Flow from Financing Activities |
---|---|
Mar2023 | ₹9.09 Cr |
Mar2022 | ₹-19 Cr |
Mar2021 | ₹-5.84 Cr |
Mar2020 | ₹-14 Cr |
Mar2019 | ₹-6.07 Cr |
How is Cash Flow from Financing Activities of AMBALAL SARABHAI ENTERPRISES Trending?
Years | Cash Flow from Financing Activities | % Change | |
---|---|---|---|
Mar2023 | ₹9.09 Cr | Positive | |
Mar2022 | ₹-19 Cr | Negative | |
Mar2021 | ₹-5.84 Cr | Negative | |
Mar2020 | ₹-14 Cr | Negative | |
Mar2019 | ₹-6.07 Cr | - |
Compare Cash Flow from Financing Activities of peers of AMBALAL SARABHAI ENTERPRISES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
AMBALAL SARABHAI ENTERPRISES | ₹348.3 Cr | -3.9% | 1.5% | 110.6% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹361,916.0 Cr | -0.1% | -6.3% | 53.5% | Stock Analytics | |
CIPLA | ₹115,034.0 Cr | 1% | -5% | 53.3% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹105,929.0 Cr | 1.1% | 2.2% | 26% | Stock Analytics | |
DIVIS LABORATORIES | ₹104,873.0 Cr | 3.2% | 15.3% | 23.6% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹100,322.0 Cr | 3.9% | -1.7% | 85.2% | Stock Analytics |
AMBALAL SARABHAI ENTERPRISES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
AMBALAL SARABHAI ENTERPRISES | -3.9% |
1.5% |
110.6% |
SENSEX | -0.6% |
0.3% |
21.8% |
You may also like the below Video Courses